Alumis Future Growth
Future criteria checks 0/6
Alumis's earnings are forecast to decline at 13.2% per annum while its annual revenue is expected to grow at 87.8% per year. EPS is expected to grow by 39% per annum.
Key information
-13.2%
Earnings growth rate
39.0%
EPS growth rate
Pharmaceuticals earnings growth | 22.9% |
Revenue growth rate | 87.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Jul 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -279 | -301 | N/A | 3 |
12/31/2025 | N/A | -274 | -265 | N/A | 3 |
12/31/2024 | N/A | -251 | -232 | N/A | 3 |
3/31/2024 | N/A | -169 | -144 | -140 | N/A |
12/31/2023 | N/A | -155 | -134 | -130 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALMS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALMS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALMS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ALMS is forecast to have no revenue next year.
High Growth Revenue: ALMS is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALMS's Return on Equity is forecast to be high in 3 years time